SCHEMBL1306085

SCHEMBL1306085

Oc1ccc(-c2nnc(-c3ccccc3)c(-c3ccccc3)n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 1.00
ALDH1A1 P00352 4/20 0.69
SMN1; SMN2 Q16637 5/20 0.66
KMT2A Q03164 8/20 0.61
MEN1 O00255 7/20 0.61
NTSR1 P30989 1/20 0.55
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
USP2 O75604 3/20 0.54
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
TP53 P04637 1/20 0.54
PKM P14618 1/20 0.54
MMP3 P08254 1/20 0.50
BCL2L1 Q07817 1/20 0.50
GAA P10253 2/20 0.49
ADORA2A P29274 3/20 0.48
ADORA1 P30542 3/20 0.48
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13108707 0.92 MAPT (0.85) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL29556760 0.90 ALDH1A1 (0.81) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL2849974 0.90 ALDH1A1 (0.81) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL32668864 0.90 ALDH1A1 (0.81) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL13108734 0.88 ALDH1A1 (0.79) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL3445210 0.88 SMN1; SMN2 (0.81) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL15305956 0.82 MEN1 (0.80) MAPTSMN1; SMN2KMT2AMEN1NTSR1
SCHEMBL24715264 0.81 MAPT (0.69) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL11772051 0.81 ALDH1A1 (0.69) MAPTALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL20387001 0.81 ALDH1A1 (1.00) MAPTALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053573-B2 Monomer 5, 6-diphenyl-1.2.4-traizinic derivatives and the use thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-11-08 US disclosed
US-8053573-B2 Monomer 5, 6-diphenyl-1.2.4-traizinic derivatives and the use thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-11-08 US disclosed
US-8053573-B2 Monomer 5, 6-diphenyl-1.2.4-traizinic derivatives and the use thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-11-08 US disclosed
EP-1751122-B1 MONOMER 5,6-DIPHENYL-1,2,4-TRIAZINIC DERIVATIVES AND THE USE THEREOF FABRE PIERRE DERMO COSMETIQUE (FR) 2010-03-17 EP disclosed
US-20080299055-A1 Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-12-04 US disclosed
US-20080299055-A1 Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-12-04 US disclosed
US-20080299055-A1 Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof PIERRE FABRE DERMO-COSMETIQUE (FR) 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299055-A1 Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof POT1, TELO2, CLIC1 MAPT 4453/4885ALDH1A1 581/4885SMN1; SMN2 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.